Please provide your email address to receive an email when new articles are posted on . In the phase 2 PULSAR trial, treatment with sotatercept for 24 weeks resulted in greater reduction in pulmonary ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among adults with pulmonary arterial hypertension, ...

Thus, the pattern of the resolution of pulmonary vascular disease after mitral-valve surgery is not clear. Furthermore, the influence of cardiopulmonary bypass and the characteristics of the ...

An ongoing multicenter study in Japan will evaluate reductions in pulmonary vascular resistance 8 months after initiating the combination therapy in pulmonary arterial hypertension. An ongoing study ...

Vascular surgeons are doctors who treat diseases and problems within the vascular system, the network of arteries and veins that carry blood throughout the body. Vascular surgeons do more than surgery ...

A randomized controlled trial shows that the TNF inhibitor etanercept improves cerebral blood flow, vascular reactivity, and ...

A multi-species synbiotic supplement has led to measurable improvements in weight, metabolic control and cardiovascular risk ...

Hypotension or low blood pressure prevents organs from receiving the necessary amount of blood to function. An acute reduction in blood pressure can result in shock syndrome, whereas long-term ...

Vascular dementia is the second most common cause of dementia in older people. Dementia is a group of conditions that affects brain functions such as thinking, memory, and reasoning. Vascular dementia ...